Argyle Capital Management Inc. has filed its 13F form on October 25, 2024 for Q3 2024 where it was disclosed a total value porftolio of $248 Million distributed in 124 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $12.2M, Eli Lilly & CO with a value of $10.2M, Jpmorgan Chase & CO with a value of $6.23M, Mckesson Corp with a value of $6.16M, and Amgen Inc with a value of $6.12M.

Examining the 13F form we can see an increase of $7.41M in the current position value, from $240M to 248M.

Below you can find more details about Argyle Capital Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $248 Million
Healthcare: $51.4 Million
Technology: $41.3 Million
Industrials: $36.4 Million
Financial Services: $31.8 Million
Energy: $20.2 Million
Consumer Cyclical: $17.7 Million
Consumer Defensive: $14.2 Million
Utilities: $12.9 Million
Other: $21.8 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 124
  • Current Value $248 Million
  • Prior Value $240 Million
  • Filing
  • Period Q3 2024
  • Filing Date October 25, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 72 stocks
Track This Portfolio

Track Argyle Capital Management Inc. Portfolio

Follow Argyle Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.